MEDICLINIC INTERNATIONAL PLC
ISIN: GB00B8HX8Z88 | LEI: 2138002S5BSBIZTD5I60
Country: United Kingdom
6th Floor, 65 Gresham Street, EC2V 7NQ London – United Kingdom
| Line item in (gbp) | 01.04.2020 | 01.04.2021 | 01.04.2022 |
|---|---|---|---|
| Assets | N/A | 6,672,000,000.00 | 7,207,000,000.00 |
| Noncurrent Assets | N/A | 5,440,000,000.00 | 5,733,000,000.00 |
| Property Plant And Equipment | N/A | 4,052,000,000.00 | 4,385,000,000.00 |
| Investment Accounted For Using Equity Method | N/A | 171,000,000.00 | 165,000,000.00 |
| Deferred Tax Assets | N/A | 34,000,000.00 | 32,000,000.00 |
| Noncurrent Recognised Assets Defined Benefit Plan | N/A | 110,000,000.00 | 1,000,000.00 |
| Current Assets | N/A | 1,232,000,000.00 | 1,474,000,000.00 |
| Inventories | N/A | 109,000,000.00 | 97,000,000.00 |
| Trade And Other Current Receivables | N/A | 826,000,000.00 | 834,000,000.00 |
| Current Loans And Receivables | N/A | 2,000,000.00 | 6,000,000.00 |
| Cash and cash equivalents | 329,000,000.00 | 294,000,000.00 | 534,000,000.00 |
| Equity And Liabilities | N/A | 6,672,000,000.00 | 7,207,000,000.00 |
| Equity | 3,003,000,000.00 | 2,967,000,000.00 | 3,246,000,000.00 |
| Issued Capital | N/A | 74,000,000.00 | 74,000,000.00 |
| Retained Earnings | N/A | 4,523,000,000.00 | 4,597,000,000.00 |
| Share Premium | N/A | 690,000,000.00 | 690,000,000.00 |
| Other Reserves | N/A | -2,438,000,000.00 | -2,254,000,000.00 |
| Equity Attributable To Owners Of Parent | N/A | 2,849,000,000.00 | 3,107,000,000.00 |
| Noncontrolling Interests | N/A | 118,000,000.00 | 139,000,000.00 |
| Liabilities | N/A | 3,705,000,000.00 | 3,961,000,000.00 |
| Noncurrent Liabilities | N/A | 3,021,000,000.00 | 3,138,000,000.00 |
| Noncurrent Provisions | N/A | 37,000,000.00 | 37,000,000.00 |
| Deferred Tax Liabilities | N/A | 425,000,000.00 | 432,000,000.00 |
| Noncurrent Recognised Liabilities Defined Benefit Plan | N/A | 127,000,000.00 | 119,000,000.00 |
| Noncurrent Derivative Financial Liabilities | N/A | 124,000,000.00 | 128,000,000.00 |
| Longterm Borrowings | N/A | 1,686,000,000.00 | 1,688,000,000.00 |
| Current Liabilities | N/A | 684,000,000.00 | 823,000,000.00 |
| Current Provisions | N/A | 19,000,000.00 | 38,000,000.00 |
| Trade And Other Current Payables | N/A | 498,000,000.00 | 586,000,000.00 |
| Current Recognised Liabilities Defined Benefit Plan | N/A | 14,000,000.00 | 20,000,000.00 |
| Current Derivative Financial Liabilities | N/A | 2,000,000.00 | 1,000,000.00 |
| Line item in (gbp) | 01.04.2020/ 01.04.2021 |
01.04.2021/ 01.04.2022 |
|---|---|---|
| Revenue | 2,995,000,000.00 | 3,233,000,000.00 |
| Other Income | 13,000,000.00 | 25,000,000.00 |
| Raw Materials And Consumables Used | 719,000,000.00 | 770,000,000.00 |
| Services Expense | 147,000,000.00 | 169,000,000.00 |
| Employee Benefits Expense | 1,448,000,000.00 | 1,522,000,000.00 |
| Depreciation And Amortisation Expense | 217,000,000.00 | 228,000,000.00 |
| Other Gains Losses | 2,000,000.00 | -3,000,000.00 |
| Profit Loss From Operating Activities | 209,000,000.00 | 280,000,000.00 |
| Finance Income | 4,000,000.00 | 6,000,000.00 |
| Finance Costs | 99,000,000.00 | 74,000,000.00 |
| Share Of Profit Loss Of Associates And Joint Ventures Accounted For Using Equity Method | -70,000,000.00 | -1,000,000.00 |
| Profit Loss Before Tax | 104,000,000.00 | 211,000,000.00 |
| Income Tax Expense Continuing Operations | 25,000,000.00 | 41,000,000.00 |
| Profit (loss) | 79,000,000.00 | 170,000,000.00 |
| Profit Loss Attributable To Owners Of Parent | 68,000,000.00 | 151,000,000.00 |
| Profit Loss Attributable To Noncontrolling Interests | 11,000,000.00 | 19,000,000.00 |
| Line item in (gbp) | 01.04.2020 | 01.04.2021 | 01.04.2022 |
|---|---|---|---|
| Profit (loss) | N/A | 79,000,000.00 | 170,000,000.00 |
| Cash Flows From Used In Operations | N/A | 330,000,000.00 | 663,000,000.00 |
| Interest Paid Classified As Operating Activities | N/A | 70,000,000.00 | 69,000,000.00 |
| Interest Received Classified As Operating Activities | N/A | 4,000,000.00 | 6,000,000.00 |
| Income Taxes Paid Refund Classified As Operating Activities | N/A | 29,000,000.00 | 46,000,000.00 |
| Cash Flows From Used In Operating Activities | N/A | 235,000,000.00 | 554,000,000.00 |
| Cash Flows From Losing Control Of Subsidiaries Or Other Businesses Classified As Investing Activities | N/A | 4,000,000.00 | 0.00 |
| Cash Flows Used In Obtaining Control Of Subsidiaries Or Other Businesses Classified As Investing Activities | N/A | 2,000,000.00 | 7,000,000.00 |
| Proceeds From Sales Of Property Plant And Equipment Classified As Investing Activities | N/A | 0.00 | 1,000,000.00 |
| Cash Flows From Used In Investing Activities | N/A | -137,000,000.00 | -189,000,000.00 |
| Proceeds From Changes In Ownership Interests In Subsidiaries | N/A | 1,000,000.00 | 2,000,000.00 |
| Proceeds From Borrowings Classified As Financing Activities | N/A | 115,000,000.00 | 89,000,000.00 |
| Repayments Of Borrowings Classified As Financing Activities | N/A | 196,000,000.00 | 183,000,000.00 |
| Payments Of Lease Liabilities Classified As Financing Activities | N/A | 39,000,000.00 | 42,000,000.00 |
| Cash Flows From Used In Financing Activities | N/A | -130,000,000.00 | -149,000,000.00 |
| Increase (decrease) in cash and cash equivalents before effect of exchange rate changes | N/A | -32,000,000.00 | 216,000,000.00 |
| Effect Of Exchange Rate Changes On Cash And Cash Equivalents | N/A | -3,000,000.00 | 24,000,000.00 |
| Cash and cash equivalents | 329,000,000.00 | 294,000,000.00 | 534,000,000.00 |
Please note that some sums might not add up.
GB00B8HX8Z88
LEI2138002S5BSBIZTD5I60
Listed Stock ExchangeKeep yourself informed with the most recent updates on FinancialReports, IPOs, product advancements, and other significant news.